TrademarkDir
CANCER BREAKTHROUGHS 2020
DEAD

Serial Number

87306244

Owner

NANT HOLDINGS IP, LLC

Attorney

Michael J. McCue

Filing Date

Jan 18, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CANCER BREAKTHROUGHS 2020 Trademark

Serial Number: 87306244

CANCER BREAKTHROUGHS 2020 is a trademark filed by NANT HOLDINGS IP, LLC on January 18, 2017. The trademark is classified under Class 36 (Insurance & Financial). The application is currently no longer active.

Owner Contact Info

NANT HOLDINGS IP, LLC (233 trademarks)

11755 WILSHIRE BOULEVARD
LOS ANGELES, CA 90025

Entity Type: 16

Trademark Details

Filing Date

January 18, 2017

Registration Date

Not Registered

Published for Opposition

November 14, 2017

Goods & Services

Charitable fundraising services

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 13, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 13, 2018 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
ASSIGNED TO LIE
Oct 9, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2017 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jan 26, 2017 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2017 NWOS
NEW APPLICATION ENTERED
Jan 21, 2017 NWAP

Related Trademarks

More from this Owner

PATIENT LANGUAGE MODELS

PATIENT LANGUAGE MODELS

PATIENT LANGUAGE MODELS

PATIENT LANGUAGE MODELS

WIGIGLINK

WIGIGLINK

NANT CANCER VACCINE

NANT CANCER VACCINE

NANT CANCER VACCINE

NANT CANCER VACCINE

NANT CANCER VACCINE

NANT CANCER VACCINE